Nova Patents
AT293169T

Latency associated peptide of tgf-beta for providing latency to pharmaceutically active proteins

Abstract

A fusion protein comprising a peptide associated with latency (LAP) of TGF-1, 2, 3, 4 or 5 and a site of proteolytic cleavage of matrix metalloproteinases (MMP), for use in providing latency to a protein pharmaceutically active.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

21 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
0100551United KingdomA
75628301United States of AmericaA
0200068United KingdomW

Members21

Family members, oldest first
DocumentOfficeKind
GB0100551D0United KingdomD0
WO02055098A2World Intellectual Property Organization (WIPO)A2
US2002151478A1United States of AmericaA1
WO02055098A3World Intellectual Property Organization (WIPO)A3
EP1349944A2European Patent Office (EPO)A2
JP2004520031AJapanA
US2004147444A1United States of AmericaA1
ZA200305237BSouth AfricaB
EP1349944B1European Patent Office (EPO)B1
AT293169TThis recordAustriaT
ATE293169T1AustriaT1
DE60203692D1GermanyD1
DK1349944T3DenmarkT3
US6942853B2United States of AmericaB2
ES2240740T3SpainT3
DE60203692T2GermanyT2
AU2002219345B2AustraliaB2
US7141392B2United States of AmericaB2
US2007015253A1United States of AmericaA1
US7307147B2United States of AmericaB2
JP4201253B2JapanB2